首站-论文投稿智能助手
典型文献
Druggability of lipid metabolism modulation against renal fibrosis
文献摘要:
Renal fibrosis contributes to progressive damage to renal structure and function.It is a common pathological process as chronic kidney disease develops into kidney failure,irrespective of diverse etiologies,and eventually leads to death.However,there are no effective drugs for renal fibrosis treatment at present.Lipid aggregation in the kidney and consequent lipotoxicity always accompany chronic kidney disease and fibrosis.Numerous studies have revealed that restoring the defective fatty acid oxidation in the kidney cells can mitigate renal fibrosis.Thus,it is an important strategy to reverse the dysfunctional lipid metabolism in the kidney,by targeting critical regulators of lipid metabolism.In this review,we highlight the potential "druggability" of lipid metabolism to ameliorate renal fibrosis and provide current pre-clinical evidence,exemplified by some representative druggable targets and several other metabolic regulators with anti-renal fibrosis roles.Then,we introduce the preliminary progress of noncoding RNAs as promising anti-renal fibrosis drug targets from the perspective of lipid metabolism.Finally,we discuss the prospects and deficiencies of drug targeting lipid reprogramming in the kidney.
文献关键词:
作者姓名:
Yuan-yuan Chen;Xiao-guang Chen;Sen Zhang
作者机构:
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences&Peking Union medical college,Beijing 100050,China
引用格式:
[1]Yuan-yuan Chen;Xiao-guang Chen;Sen Zhang-.Druggability of lipid metabolism modulation against renal fibrosis)[J].中国药理学报(英文版),2022(03):505-519
A类:
Druggability,lipotoxicity,druggability
B类:
lipid,metabolism,modulation,against,renal,fibrosis,Renal,contributes,progressive,damage,structure,It,common,pathological,process,chronic,kidney,disease,develops,into,failure,irrespective,diverse,etiologies,eventually,leads,death,However,there,are,effective,drugs,treatment,Lipid,aggregation,consequent,always,accompany,Numerous,studies,have,revealed,that,restoring,defective,fatty,acid,oxidation,cells,can,mitigate,Thus,important,strategy,reverse,dysfunctional,by,targeting,critical,regulators,In,this,review,highlight,potential,ameliorate,provide,current,clinical,evidence,exemplified,some,representative,druggable,targets,several,other,metabolic,anti,roles,Then,introduce,preliminary,noncoding,RNAs,promising,from,perspective,Finally,discuss,prospects,deficiencies,reprogramming
AB值:
0.576475
相似文献
Targeted lipidomics reveals plasmalogen phosphatidylethanolamines and storage triacylglycerols as the major systemic lipid aberrations in Bietti crystalline corneoretinal dystrophy
Shijing Wu;Sin Man Lam;Huajin Li;Binhua Jiang;Zixi Sun;Tian Zhu;Xing Wei;Xuan Zou;Guanghou Shui;Ruifang Sui-Department of Ophthalmology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;State Key Laboratory of Molecular Developmental Biology,Institute of Genetics and Developmental Biology,Chinese Academy of Sciences,Beijing 100101,China;Department of Ophthalmology,The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian 350004,China;LipidALL Technologies Company Limited,Changzhou,Jiangsu 213022,China
Driving role of macrophages in transition from acute kidney injury to chronic kidney disease
Meng Xiaoming;Jin Juan;Lan Hui Yao-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhul Medical University, The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Hefei, Anhui 230032, China;School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China;Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China;The Chinese University of Hong Kong-Guangdong Academy of Sciences/Guangdong Provincial People’s Hospital Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
Effect of astragaloside Ⅳ and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics
KONG Xiang-Lin;LYU Qin;ZHANG Ya-Qi;KANG Dong-Fang;LI Chao;ZHANG Lei;GAO Zi-Chen;LIU Xin-Xin;WU Ji-Biao;LI Yun-Lun-Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Graduate School,Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China;College of Continuing Education,Shandong University of Traditional Chinese Medicine,Jinan,250355,China;Innovative Institute of Chinese Medicine and Pharmacy,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;Department of Cardiology,the Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。